Three Theories of Depression and the Promise of Psychedelics: The Drugs That Shape Us, Episode 3

Chain Reaction by ACS

In the late 1950s, a tuberculosis drug was repurposed as the world’s first antidepressant. Then the selective serotonin reuptake inhibitor (SSRI) Prozac ushered in a new era of antidepressants. Today SSRIs are some of the most widely prescribed drugs in the country, but gaps still exist in our biological understanding of mental health, the overall efficacy of antidepressants, and predicting serious side effects. In response, some scientists and physicians are turning to different classes of drugs altogether to treat depression. 

Transcripts and episode sources at acs.org/chainreaction

More description

In the late 1950s, a tuberculosis drug was repurposed as the world’s first antidepressant. Then the selective serotonin reuptake inhibitor (SSRI) Prozac ushered in a new era of antidepressants. Today SSRIs are some of the most widely prescribed drugs in the country, but gaps still exist in our biological understanding of mental health, the overall efficacy of antidepressants, and predicting serious side effects. In response, some scientists and physicians are turning to different classes of drugs altogether to treat depression. 

Transcripts and episode sources at acs.org/chainreaction

2026-08-27 56 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.